Billionaire Buys Stake In Gene Therapy Stock
Ultragenyx may not have crossed your radar but it’s already in billionaire Stan Druckenmiller’s portfolio. What has he spotted in this novel therapies for rare and ultra-rare genetic diseases firm that convinced him to take a position?
Its focus on underserved patient populations, deep pipeline of innovative products, and strong track record in obtaining regulatory approvals make it an attractive long-term investment, » Read more about: Billionaire Buys Stake In Gene Therapy Stock »
Read More
Massive Upside In Big Money Pharma Favorite?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes in the use of immune therapies for cancer treatment. Specifically, Iovance is exploring new applications of tumor infiltrating lymphocyte (TIL) therapy, utilizing cells that the human body naturally produces to attack cancerous tumors.
There was lots of hype about this next-generation cancer treatment company but its share price has been decidedly lackluster this year,
» Read more about: Massive Upside In Big Money Pharma Favorite? »
Read More
Forget AI, The Next Massive Trend Is Starting In 3,2,1…
In the early days of e-commerce, few could have imagined just how quickly video-driven, real-time product demonstrations would reshape global retail. But here we are: In China alone, live streaming e-commerce revenue soared from a roughly $64 billion market in 2019 to more than $300 billion by 2021, according to data compiled by Deloitte.
This shift,
» Read more about: Forget AI, The Next Massive Trend Is Starting In 3,2,1… »
Read More
How To Trade When Markets Hit All-time Highs
With the market near all-time highs, buying stocks can look like a worrisome proposition and it’s no surprise that many investors feel more comfortable sitting on the sidelines.
Staying out of the market entirely, though, presents an opportunity cost in the form of lost potential returns. So, just what can investors worried about the market’s performance and potential volatility do to limit their risks while still putting their money to work for them?
» Read more about: How To Trade When Markets Hit All-time Highs »
Read More
1 Rare Stock Buffett Is Buying
Warren Buffett has spent 2024 stockpiling cash, even going so far as to sell off sizeable pieces of some of his largest investments. Recently, though, Berkshire Hathaway announced that it had made some modest acquisitions, including the addition of nearly 388,000 shares of domain name registry service Verisign (NASDAQ:VRSN).
These purchases brought Berkshire Hathaway’s holdings in Verisign to 13.2 million shares,
» Read more about: 1 Rare Stock Buffett Is Buying »
Read MoreThe Ivy
3 Dividend Stocks Worth Pouncing On?
If you’re looking for steady income, dividend stocks are a powerful tool providing regular cash payouts as you wait for stock price appreciation.
While no dividend are paid out at the behest of the Board of Directors and so never guaranteed, four top dividend stocks to consider this year include Genuine Parts Company (GPC),
» Read more about: 3 Dividend Stocks Worth Pouncing On? »
Read MoreThe Spotlight
Up 94% Will This Semi Stock Keep Soaring?
Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced the market last year by a factor of over 3x, delivering a trailing 12-month return of almost 94%.
While the stock was rising gradually all year, the company’s shares soared in early December and finished the year extremely strong.
Why are Marvell shares rising,
» Read more about: Up 94% Will This Semi Stock Keep Soaring? »
Read MoreThe Daily
Will the Stock Market Crash or Soar Under President-Elect Donald Trump? Here's What History Shows.
Due to its scope and diversity, the S&P 500 (^GSPC 1.00%) is considered the best barometer for the entire U.S. stock market. The index advanced 23% in 2024, the second consecutive year in which it gained over 20%, something it last did in 1997 and 1998.